Related references
Note: Only part of the references are listed.Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis
Chengying Huang et al.
GYNECOLOGIC ONCOLOGY (2021)
Small Non-Coding-RNA in Gynecological Malignancies
Shailendra Kumar Dhar Dwivedi et al.
CANCERS (2021)
Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review
Christine Fribert Thusgaard et al.
GYNECOLOGIC ONCOLOGY (2021)
Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients
Ana Barbosa et al.
FRONTIERS IN ONCOLOGY (2021)
Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition
Jiani Yang et al.
SCIENTIFIC REPORTS (2021)
Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125
Takamichi Minato et al.
GYNECOLOGIC ONCOLOGY REPORTS (2021)
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium
Eva Obermayr et al.
CANCERS (2021)
Future Screening Prospects for Ovarian Cancer
Diana Zilovic et al.
CANCERS (2021)
Incidence of Cancer Among Adults With Thrombocytosis in Ontario, Canada
Vasily Giannakeas et al.
JAMA NETWORK OPEN (2021)
Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy
Mikolaj Piotr Zaborowski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
Lara Paracchini et al.
CLINICAL CANCER RESEARCH (2021)
Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Du-Bois Asante et al.
CANCER LETTERS (2020)
Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy
Xiaoming Zhong et al.
MOLECULAR CANCER (2020)
Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP-Seq in neoadjuvant chemotherapy-treated advanced ovarian cancer
Tomoko Noguchi et al.
ONCOLOGY LETTERS (2020)
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
Mi-Ryung Han et al.
CANCER RESEARCH AND TREATMENT (2020)
Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer
Alka Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study
Mariana Cartaxo Alves et al.
TUMOR BIOLOGY (2020)
Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis
Wei Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer A prospective observational study
Miseon Kim et al.
MEDICINE (2019)
Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing
Naoyuki Iwahashi et al.
SCIENTIFIC REPORTS (2019)
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
Roxane Mari et al.
CANCERS (2019)
Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis
Boxuan Li et al.
GENE (2019)
Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples
Dana Dvorska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
Anquan Shang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Exosomes promote pre-metastatic niche formation in ovarian cancer
Wenlong Feng et al.
MOLECULAR CANCER (2019)
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
A. Gonzalez-Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer
Esther Schwich et al.
CANCERS (2019)
Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA
Lijun Wang et al.
CANCER CELL INTERNATIONAL (2019)
Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
Yingchao Hu et al.
ONCOTARGETS AND THERAPY (2019)
The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing
Michael A. Gordon et al.
MOLECULAR CARCINOGENESIS (2019)
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Kevin K. Lin et al.
CANCER DISCOVERY (2019)
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer
Jaana Oikkonen et al.
JCO PRECISION ONCOLOGY (2019)
Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
Sewha Kim et al.
JOURNAL OF CANCER (2019)
ASSESSMENT OF OVARIAN TUMORS WITH TUMOR EDUCATED PLATELETS (TEPS)
J. M. J. Piek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong-Man Kim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells
Eva Obermayr et al.
ONCOTARGET (2018)
Folic Acid Targeting for Efficient Isolation and Detection of Ovarian Cancer CTCs from Human Whole Blood Based on Two-Step Binding Strategy
Liju Nie et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway
Suxian Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Lydia Giannopoulou et al.
GYNECOLOGIC ONCOLOGY (2018)
Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists
Somak Roy et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Rebecca C. Arend et al.
MOLECULAR CANCER RESEARCH (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Yuxuan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
Jiayu Shen et al.
ONCOTARGETS AND THERAPY (2018)
Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer
Yan-xiu Guo et al.
Oncotarget (2018)
PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
Asuka Morikawa et al.
Oncotarget (2018)
Next-generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug-resistant recurrent ovarian cancer
Zhen-Hua Du et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker
Xuehui Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
Mette O. Agerbaek et al.
NATURE COMMUNICATIONS (2018)
Cancer of the ovary, fallopian tube, and peritoneum
Jonathan S. Berek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Integrated extracellular microRNA profiling for ovarian cancer screening
Akira Yokoi et al.
NATURE COMMUNICATIONS (2018)
Potential clinical applications of circulating cell-free DNA in ovarian cancer patients
Ana Barbosa et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2018)
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele et al.
CLINICAL CANCER RESEARCH (2017)
Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis
Meng-Meng Jia et al.
ONCOTARGET (2017)
Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer
Wei Wei et al.
ONCOTARGET (2017)
Optimizing treatment in recurrent epithelial ovarian cancer
Giacomo Corrado et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer
Maria Lee et al.
GYNECOLOGIC ONCOLOGY (2017)
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
S. B. Coburn et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review
Juntaro Matsuzaki et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
Elizabeth L. Christie et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Exosomes: Key mediators of metastasis and pre-metastatic niche formation
Richard J. Lobb et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system
Pawel Sadlecki et al.
TUMOR BIOLOGY (2017)
Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
Bi Wang et al.
ONCOLOGY LETTERS (2017)
Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer
Magdalena Ratajska et al.
ONCOTARGET (2017)
A combination of circulating miRNAs for the early detection of ovarian cancer
Akira Yokoi et al.
ONCOTARGET (2017)
RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
Lydia Giannopoulou et al.
ONCOTARGET (2017)
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
Eva Obermayr et al.
ONCOTARGET (2017)
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer
Issam Chebouti et al.
ONCOTARGET (2017)
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Yuji Mishima et al.
CELL REPORTS (2017)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter et al.
GENOME MEDICINE (2017)
Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer
Kevin M Elias et al.
eLife (2017)
Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer
Nidal Muhanna et al.
SCIENTIFIC REPORTS (2017)
Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients
Ann Rita Halvorsen et al.
DISEASE MARKERS (2017)
Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer
Tesfaye Worku et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2017)
Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer
Linjie Zhao et al.
CANCER RESEARCH (2017)
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
M. Moschetta et al.
ANNALS OF ONCOLOGY (2016)
Characterization of the cell-free DNA released by cultured cancer cells
Abel Jacobus Bronkhorst et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening
Paul A. Cohen et al.
BMC MEDICINE (2016)
Origins, structures, and functions of circulating DNA in oncology
A. R. Thierry et al.
CANCER AND METASTASIS REVIEWS (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes
M. Martin et al.
CELL DEATH AND DIFFERENTIATION (2016)
TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
Licia Rivoltini et al.
CLINICAL CANCER RESEARCH (2016)
Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?
Felix Leung et al.
CLINICAL CHEMISTRY (2016)
An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Ovarian Cancer, Version 1.2016
Robert J. Morgan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Ian J. Jacobs et al.
LANCET (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cell-free DNA as a diagnostic marker for cancer: current insights
Samanta Salvi et al.
ONCOTARGETS AND THERAPY (2016)
What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
Joyce F. Liu et al.
CURRENT ONCOLOGY REPORTS (2016)
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
Chi Lam Au Yeung et al.
NATURE COMMUNICATIONS (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
An overview of long non-coding RNAs in ovarian cancers
Matthieu Meryet-Figuiere et al.
ONCOTARGET (2016)
Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma
Ikhlak Ahmed et al.
ONCOTARGET (2016)
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
Xiaodan Meng et al.
ONCOTARGET (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine A. Parkinson et al.
PLOS MEDICINE (2016)
Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
Ao Huang et al.
JOURNAL OF CANCER (2016)
Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma
Ruoyu Zhang et al.
SCIENTIFIC REPORTS (2016)
Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high-grade serous carcinoma on the ARIEL2 trial.
Anna Piskorz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Myron G. Best et al.
CANCER CELL (2015)
Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy
Chiara Della Pepa et al.
CANCER TREATMENT REVIEWS (2015)
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
M. Zuberi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)
Michael L. Pearl et al.
GYNECOLOGIC ONCOLOGY (2015)
Lavage of the Uterine Cavity for Molecular Detection of Mullerian Duct Carcinomas: A Proof-of-Concept Study
Elisabeth Maritschnegg et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Sequencing small genomic targets with high efficiency and extreme accuracy
Michael W. Schmitt et al.
NATURE METHODS (2015)
Detection of Ultra-Rare Mitochondrial Mutations in Breast Stem Cells by Duplex Sequencing
Eun Hyun Ahn et al.
PLOS ONE (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
Ying-chun Gao et al.
TUMOR BIOLOGY (2015)
Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters
Samreen Naz et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Oncogenes associated with drug resistance in ovarian cancer
Xia Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
Ningwei Li et al.
PLOS ONE (2015)
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
Elena Pereira et al.
PLOS ONE (2015)
A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer
Xiaowen Hu et al.
CANCER CELL (2014)
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Sonia A. Melo et al.
CANCER CELL (2014)
ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
Jan Dominik Kuhlmann et al.
CLINICAL CHEMISTRY (2014)
The evolution of the unstable cancer genome
Rebecca A. Burrell et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer
Michael L. Pearl et al.
GYNECOLOGIC ONCOLOGY (2014)
A repertoire of biomarkers helps in detection and assessment of therapeutic response in epithelial ovarian cancer
Sharmistha Choudhuri et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Detecting and characterizing circular RNAs
William R. Jeck et al.
NATURE BIOTECHNOLOGY (2014)
Survival of Australian women with invasive epithelial ovarian cancer: a population-based study
Satyamurthy Anuradha et al.
MEDICAL JOURNAL OF AUSTRALIA (2014)
Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer
Britt K. Erickson et al.
OBSTETRICS AND GYNECOLOGY (2014)
Upregulation of NEK2 is associated with drug resistance in ovarian cancer
Xia Liu et al.
ONCOLOGY REPORTS (2014)
MiR-26a Promotes Ovarian Cancer Proliferation and Tumorigenesis
Wenjing Shen et al.
PLOS ONE (2014)
Circular RNAs: diversity of form and function
Erika Lasda et al.
RNA (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma
Shu-biao Ye et al.
ONCOTARGET (2014)
Cooperation of Factor VII-Activating Protease and Serum DNase I in the Release of Nucleosomes From Necrotic Cells
Femke Stephan et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA
John A. Martignetti et al.
NEOPLASIA (2014)
Modeling nuclear molecule release during in vitro cell death
Christian Beyer et al.
AUTOIMMUNITY (2013)
High-Resolution Profiling of Fetal DNA Clearance from Maternal Plasma by Massively Parallel Sequencing
Stephanie C. Y. Yu et al.
CLINICAL CHEMISTRY (2013)
Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients
Joyce F. Liu et al.
GYNECOLOGIC ONCOLOGY (2013)
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium
Eva Obermayr et al.
GYNECOLOGIC ONCOLOGY (2013)
A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA
Qing Zhang et al.
GYNECOLOGIC ONCOLOGY (2013)
One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles
Jin Hyun Kim et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Characterization and proteomic analysis of ovarian cancer-derived exosomes
Bing Liang et al.
JOURNAL OF PROTEOMICS (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Circular RNAs are abundant, conserved, and associated with ALU repeats
William R. Jeck et al.
RNA (2013)
Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers
Isaac Kinde et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
Jan Dominik Kuhlmann et al.
BMC CANCER (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients
Florent Mouliere et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death
Christian Beyer et al.
INNATE IMMUNITY (2012)
Mechanism of Release and Fate of Excised Oligonucleotides during Nucleotide Excision Repair
Michael G. Kemp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Frequent SLIT2 Promoter Methylation in the Serum of Patients with Ovarian Cancer
R. Dong et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma
Hui Chen et al.
PATHOLOGY (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Identification of Luminal Breast Cancers That Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow-Derived Cells
Hanna S. Kuznetsov et al.
CANCER DISCOVERY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Natural history and outcome of mucinous carcinoma of the ovary
Maria B. Schiavone et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy
Marco Agostini et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes
Jesse W. Rowley et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Origin, translocation and destination of extracellular occurring DNA - A new paradigm in genetic behaviour
Dimetrie L. Peters et al.
CLINICA CHIMICA ACTA (2011)
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer
Amy E. BonDurant et al.
GYNECOLOGIC ONCOLOGY (2011)
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
Andres Poveda et al.
GYNECOLOGIC ONCOLOGY (2011)
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
Thomas E. Liggett et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Caspase-1-induced pyroptotic cell death
Edward A. Miao et al.
IMMUNOLOGICAL REVIEWS (2011)
Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients
Pauline Wimberger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based Chemotherapy
Bahriye Aktas et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
Eva Obermayr et al.
BMC CANCER (2010)
Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker
Aparna A. Kamat et al.
CANCER (2010)
Circulating Tumor Cells: Will They Be Clinically Useful?
Nancy J. Nelson
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Alain R. Thierry et al.
NUCLEIC ACIDS RESEARCH (2010)
Targeting p53 for novel anticancer therapy
Zhen Wang et al.
TRANSLATIONAL ONCOLOGY (2010)
Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum
Feng Gang et al.
UROLOGY (2010)
Platelets actively sequester angiogenesis regulators
Giannoula Lakka Klement et al.
BLOOD (2009)
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
Jianghong Li et al.
BMC CANCER (2009)
Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy
Chao Cheng et al.
CANCER SCIENCE (2009)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Quantification of Free Plasma DNA Before and After Chemotherapy in Patients With Advanced Epithelial Ovarian Cancer
Elisa Capizzi et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
Tina Fan et al.
GYNECOLOGIC ONCOLOGY (2009)
An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
Her-Young Su et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma
Anatoliy Melnikov et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
High-Throughput Proteomics Detection of Novel Splice Isoforms in Human Platelets
Karen A. Power et al.
PLOS ONE (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
Steffen Runz et al.
GYNECOLOGIC ONCOLOGY (2007)
Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR
Vanessa Garcia Moreira et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
EM Swisher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
Detection of p53 mutations in the plasma DNA of patients with ovarian cancer
J Otsuka et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer
PL Judson et al.
GYNECOLOGIC ONCOLOGY (2003)
Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis
C Marth et al.
CANCER (2002)
Share Paper
